Is a $37 Million Stake Trim in Sotera Health Hiding a Major Red Flag? Discover the Shocking Truth!

In a significant move on February 17, 2026, MIG Capital revealed it had reduced its holdings in Sotera Health (NASDAQ:SHC) by selling 2,262,292 shares, a transaction valued at approximately $37.41 million based on quarterly average pricing. This decision follows a broader trend of portfolio adjustments amidst fluctuating market conditions.

According to an SEC filing from the same date, the reduction in stake took place during the fourth quarter of 2025. Despite this cutback, Sotera Health still accounts for about 5.88% of MIG Capital’s total assets under management. Following the sale, the total value of this position fell by $31.83 million, a figure that reflects both trading activities and shifting share prices.

• Top Holdings After the Filing:
• NASDAQ:META: $52.45 million (8.9% of AUM)
• NASDAQ:DXCM: $40.19 million (6.8% of AUM)
• NASDAQ:SHC: $34.65 million (5.9% of AUM)
• NASDAQ:MSFT: $34.25 million (5.8% of AUM)
• NASDAQ:CELH: $33.93 million (5.8% of AUM)

As of the last trading session, Sotera Health shares were priced at $13.41, showing an 18% increase over the past year. This growth, however, is slightly below the S&P 500’s gain of approximately 20% during the same timeframe.

Sotera Health plays a crucial role in the healthcare ecosystem by providing sterilization services, lab testing, and advisory solutions for the medical device, pharmaceutical, and food industries. Their service-based business model generates revenue primarily through sterilization and laboratory testing services tailored for regulated industries.

In recent years, Sotera has demonstrated consistent growth, marking its 20th consecutive year of revenue growth. In 2025, the company reported a 5.7% increase in sales to $1.16 billion, while adjusted EBITDA rose by 8.2% to approximately $594 million. Notably, net income nearly doubled from the previous year, reaching $78 million, underscoring its strong financial performance.

Even with the recent reduction in holdings, MIG Capital's continued investment in Sotera Health suggests a measured approach rather than a loss of confidence. With the stock having declined about 24% so far this year, the trimming of shares may reflect a strategy to lock in gains amid market volatility.

Looking ahead, Sotera Health is optimistic about its growth trajectory. The company projects a revenue increase of 5% to 6.5% for 2026, along with an adjusted EBITDA growth estimate of 5.5% to 7%. Such projections may explain why MIG Capital still maintains a significant stake in the company.

However, potential investors should exercise caution. The Motley Fool’s Stock Advisor analyst team recently identified their top picks for investment, and notably, Sotera Health was not included in this list. This selective recommendation highlights the competitive landscape and the importance of thorough research before making investment decisions.

In summary, while Sotera Health has shown resilience and growth, the recent moves by MIG Capital to adjust its holdings serve as a reminder of the dynamic nature of the stock market. As always, due diligence and strategic thinking are essential for investors navigating this complex environment.